John Eklund

1.0k total citations
13 papers, 289 citations indexed

About

John Eklund is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, John Eklund has authored 13 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Immunology and 4 papers in Dermatology. Recurrent topics in John Eklund's work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). John Eklund is often cited by papers focused on CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). John Eklund collaborates with scholars based in United States, Canada and United Kingdom. John Eklund's co-authors include Timothy M. Kuzel, Mary F. Mulcahy, Steve Trifilio, Philip J. Bailey, Aaron Scott, Adam Lane, Deborah Wilson, Sandra J. Horning, Shuli Li and Erwin Robin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Immunotherapy.

In The Last Decade

John Eklund

11 papers receiving 286 citations

Peers

John Eklund

ONCOL

IMMUN

PRM

EPIDE

Kazuhiko Yamamoto Japan

Alfonsus Johannes Maria van den Eertwegh Netherlands

Mileka Gilbert United States

Søren Ulrik Sønder United States

Benno Traub Germany

Alexa J. Resler United States

Jason Law United States

Jacopo Angelini Italy

Toshihiko Akimoto Japan

Sarah E. Fenton United States

Kazuhiko Yamamoto Japan

John Eklund

81 ×0.6

ONCOL

227 ×2.0

IMMUN

90 ×1.5

35 ×0.7

PRM

26 ×0.8

EPIDE

Citations per year, relative to John Eklund John Eklund (= 1×) peers Kazuhiko Yamamoto

Countries citing papers authored by John Eklund

Since Specialization

Citations

This map shows the geographic impact of John Eklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Eklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Eklund more than expected).

Fields of papers citing papers by John Eklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Eklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Eklund. The network helps show where John Eklund may publish in the future.

Co-authorship network of co-authors of John Eklund

This figure shows the co-authorship network connecting the top 25 collaborators of John Eklund. A scholar is included among the top collaborators of John Eklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Eklund. John Eklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chiang, Harrah, et al.. (2024). Report of Cholangiocarcinoma With Transheterozygous BRCA1 and BRCA2 Co-mutation. Cureus. 16(5). e60767–e60767.

Sirota, Ronald L., et al.. (2018). Acute myeloid leukemia with t(4;12)(q12;p13) treated with an allogeneic stem cell transplant: A case report and review of the literature. Leukemia Research Reports. 9. 76–78.

Atchison, Elizabeth A., John Eklund, Lili Wang, et al.. (2010). A Pilot Study of Denileukin Diftitox (DD) in Combination With High-dose Interleukin-2 (IL-2) for Patients With Metastatic Renal Cell Carcinoma (RCC). Journal of Immunotherapy. 33(7). 716–722. 14 indexed citations

Kuzel, Timothy M., Shuli Li, John Eklund, et al.. (2007). Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497. Leukemia & lymphoma. 48(12). 2397–2402. 15 indexed citations

Treaba, Diana O., John Eklund, Jeffrey D. Wayne, Beverly P. Nelson, & Jane N. Winter. (2006). Classical Hodgkin's Lymphoma Presenting with Tongue Involvement: A Case Report and Review of the Literature. Clinical Lymphoma & Myeloma. 6(5). 410–413. 6 indexed citations

Eklund, John, Mark Kozloff, Borko Jovanovic, et al.. (2006). Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer. Cancer. 106(11). 2459–2465. 20 indexed citations

Eklund, John, et al.. (2006). T_reg depletion with denileukin difititox (DD) enhances lymphocytosis and eosinphilia in patients treated with high-dose IL-2 (HDIL-2) for metastatic renal cell cancer (MRCC). Journal of Clinical Oncology. 24(18_suppl). 14627–14627. 1 indexed citations

Eklund, John & Timothy M. Kuzel. (2005). Interleukin-2 in the Treatment of Renal Cell Carcinoma and Malignant Melanoma. Cancer treatment and research. 126. 263–287. 14 indexed citations

Eklund, John, Steve Trifilio, & Mary F. Mulcahy. (2005). Chemotherapy dosing in the setting of liver dysfunction.. PubMed. 19(8). 1057–63; discussion 1063. 73 indexed citations

10.

Eklund, John & Timothy M. Kuzel. (2005). Denileukin diftitox: a concise clinical review. Expert Review of Anticancer Therapy. 5(1). 33–38. 43 indexed citations

11.

Eklund, John, Edie Weller, Timothy M. Kuzel, et al.. (2005). Phase II study of denileukin diftitox for previously treated low grade non-Hodgkin’s lymphoma: E1497 final report. Journal of Clinical Oncology. 23(16_suppl). 6684–6684. 1 indexed citations

12.

Eklund, John & Timothy M. Kuzel. (2004). A review of recent findings involving interleukin-2-based cancer therapy. Current Opinion in Oncology. 16(6). 542–546. 71 indexed citations

13.

Bailey, Philip J., et al.. (2003). A double‐blind randomized vehicle‐controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity. International Journal of Cosmetic Science. 25(4). 183–188. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact